Congo vs Lesotho: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Congo
1.6%
in 2024
Lesotho
1.4%
in 2024
Congo rank
19th
Lesotho rank
20th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Congo
- Lesotho
How they compare
Congo currently reports 1.6% against 1.4% in Lesotho, a difference of 0.2%.
That makes Congo's figure about 1.1 times Lesotho's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Lesotho ahead.
Congo ranks 19th and Lesotho ranks 20th of 215 countries.
Lesotho has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.6% | 3.3% | 1.7% | Lesotho |
| 2020s | 1.6% | 1.8% | 0.1% | Lesotho |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Congo or Lesotho?
- Congo, at 1.6% against 1.4% in Lesotho as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Congo and Lesotho?
- 0.2%, with Congo ahead.
- How many years of comparable data are there for Congo and Lesotho?
- 10 years are reported by both, from 2015 to 2024.
- How do Congo and Lesotho rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Congo ranks 19th and Lesotho ranks 20th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.